BERTIN CORP

BERTIN CORP specializes in advanced biotechnology research and life sciences R&D, with a focus on developing and supplying specialized analytical tools and immunoassay kits for biomedical applications. Their technical expertise centers on the design, procurement, and integration of high-precision laboratory instrumentation and diagnostic reagents, particularly in the area of peptide-based biomarker detection, including acylated ghrelin ELISA kits. The firm demonstrates deep proficiency in assay validation, sample preparation workflows, and the deployment of next-generation analytical platforms such as the PreCellys Evolution system for tissue homogenization and molecular extraction. Their work supports critical research in endocrinology, metabolic disorders, and proteomic profiling, positioning them as a niche provider of validated, research-grade solutions for life science laboratories. The company maintains a consistent relationship with the Department of Health and Human Services, delivering mission-critical research tools and diagnostic reagents that enable federal health agencies to advance biomedical investigations. Their engagements typically involve the acquisition of proprietary assay kits and laboratory equipment tailored to in vitro diagnostic research, indicating a trusted vendor status within HHS-funded scientific programs. BERTIN CORP operates primarily under NAICS 541714 and 541715, focusing on biotechnology R&D and broader life sciences research services. They serve the vertical markets of molecular diagnostics, proteomics, and translational medicine, filling a specialized gap between instrument manufacturing and applied biological research. Their market positioning is that of a precision supplier to federally funded scientific teams requiring validated, reproducible tools for complex biological analysis. As a small business structured as a 2L entity based in Rockville, Maryland, BERTIN CORP leverages its proximity to federal research hubs to support government science initiatives. While no formal government certifications are listed, their consistent delivery of compliant, research-grade products to HHS suggests adherence to rigorous quality and regulatory standards in laboratory reagent and instrument procurement.